|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU2002365057A1
(en)
|
2001-12-21 |
2003-07-30 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
|
ATE552236T1
(de)
*
|
2003-01-14 |
2012-04-15 |
Cytokinetics Inc |
Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz
|
|
AU2004206955A1
(en)
|
2003-01-21 |
2004-08-05 |
Archemix Corp. |
Aptamer therapeutics useful in ocular pharmacotherapy
|
|
EP1605752B1
(en)
|
2003-03-27 |
2011-09-14 |
Cytokinetics, Inc. |
Sulfonamides for the treatment of congestive heart failure, their compositions and uses.
|
|
JP2007516176A
(ja)
|
2003-06-20 |
2007-06-21 |
アムジエン・インコーポレーテツド |
ピペラジン誘導体及び使用方法
|
|
ES2522579T3
(es)
|
2004-06-17 |
2014-11-17 |
Cytokinetics, Inc. |
Compuestos, composiciones y métodos
|
|
US20060173183A1
(en)
*
|
2004-12-31 |
2006-08-03 |
Alantos Pharmaceuticals, Inc., |
Multicyclic bis-amide MMP inhibitors
|
|
TW200718692A
(en)
|
2005-04-22 |
2007-05-16 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
|
WO2007078815A2
(en)
|
2005-12-16 |
2007-07-12 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
SA08290245B1
(ar)
|
2007-04-23 |
2012-02-12 |
استرازينيكا ايه بي |
مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
|
|
US20090192168A1
(en)
|
2008-01-04 |
2009-07-30 |
Alex Muci |
Compounds, Compositions and Methods
|
|
WO2010033701A2
(en)
|
2008-09-19 |
2010-03-25 |
Genzyme Corporation |
Inhibitors of sphingosine kinase 1
|
|
NZ596302A
(en)
|
2009-05-15 |
2014-01-31 |
Novartis Ag |
Aryl pyridine as aldosterone synthase inhibitors
|
|
US8592426B2
(en)
|
2011-01-24 |
2013-11-26 |
Hoffmann—La Roche Inc. |
Aryl-benzocycloalkyl amide derivatives
|
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
US9493412B2
(en)
|
2011-09-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
|
|
US9409917B2
(en)
|
2012-01-20 |
2016-08-09 |
Actelion Pharmaceuticals Ltd. |
Heterocyclic amide derivatives as P2X7 receptor antagonists
|
|
SMT202000071T1
(it)
|
2013-06-21 |
2020-03-13 |
Myokardia Inc |
Composti di pirimidinadione contro le condizioni cardiache
|
|
US9199945B2
(en)
|
2013-06-21 |
2015-12-01 |
MyoKardia, Inc. |
Cycloalkyl-substituted pyrimidinedione compounds
|
|
AU2014362231B2
(en)
|
2013-12-11 |
2019-04-04 |
Biogen Ma Inc. |
Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
|
|
US9663516B2
(en)
|
2014-12-18 |
2017-05-30 |
MyoKardia, Inc. |
Bicyclic-pyrimidinedione compounds
|
|
EP4234017B1
(en)
|
2015-01-22 |
2026-04-15 |
MyoKardia, Inc. |
Preparation of 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm)
|
|
CN108137517B
(zh)
|
2015-10-02 |
2022-04-12 |
先正达参股股份有限公司 |
杀微生物的噁二唑衍生物
|
|
JP2019507110A
(ja)
|
2015-12-17 |
2019-03-14 |
シンジェンタ パーティシペーションズ アーゲー |
殺微生物性オキサジアゾール誘導体
|
|
CN108368098B
(zh)
|
2015-12-18 |
2022-01-28 |
先正达参股股份有限公司 |
杀微生物的噁二唑衍生物
|
|
CA3022432A1
(en)
|
2016-04-29 |
2017-11-02 |
Board Of Regents, The University Of Texas System |
Sigma receptor binders
|
|
WO2017222951A1
(en)
|
2016-06-23 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
JP6681517B2
(ja)
|
2016-09-27 |
2020-04-15 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
ｍＧｌｕＲ２陰性アロステリック調節剤としてのクロマン、イソクロマン及びジヒドロイソベンゾフラン誘導体、組成物、及びそれらの使用
|
|
WO2018089433A1
(en)
|
2016-11-08 |
2018-05-17 |
Navitor Pharmaceuticals, Inc. |
PHENYL mTORC INHIBITORS AND USES THEREOF
|
|
JP2020023442A
(ja)
|
2016-12-19 |
2020-02-13 |
住友化学株式会社 |
オキサジアゾール化合物及び植物病害防除方法
|
|
WO2018156883A1
(en)
|
2017-02-23 |
2018-08-30 |
Board Of Regents, The University Of Texas System |
Methods of treatment for cancer, sterol homeostasis, and neurological diseases
|
|
CN110325517B
(zh)
*
|
2017-02-28 |
2021-03-02 |
南京明德新药研发有限公司 |
螺环类化合物及其应用
|
|
CA3071948A1
(en)
|
2017-08-04 |
2019-02-07 |
MyoKardia, Inc. |
Mavacamten for use in the treatment of hypertrophic cardiomyopathy
|
|
WO2019144041A1
(en)
|
2018-01-19 |
2019-07-25 |
Cytokinetics, Inc. |
Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
|
|
BR112020018094A2
(pt)
|
2018-03-08 |
2020-12-22 |
Incyte Corporation |
Compostos de aminopirazina diol como inibidores de pi3k-¿
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
JP7610985B2
(ja)
*
|
2018-06-26 |
2025-01-09 |
サイトキネティックス， インコーポレイテッド |
心臓サルコメア阻害剤
|
|
JP7438148B2
(ja)
|
2018-06-26 |
2024-02-26 |
サイトキネティックス， インコーポレイテッド |
心臓サルコメア阻害剤
|
|
MA53491A
(fr)
|
2018-08-31 |
2021-09-15 |
Cytokinetics Inc |
Inhibiteurs de sarcomes cardiaques
|
|
MX2021001380A
(es)
|
2018-08-31 |
2021-05-27 |
Xenon Pharmaceuticals Inc |
Compuestos de sulfonamida sustituidos con heteroarilo y su uso como agentes terapeuticos.
|
|
EP3999180B1
(en)
|
2019-07-17 |
2024-05-08 |
Cytokinetics, Inc. |
Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide
|
|
BR112022000523A2
(pt)
|
2019-07-17 |
2022-03-03 |
Cytokinetics Inc |
Polimorfo, métodos para preparar polimorfo, para tratar doença cardíaca, para tratar uma doença ou condição e para inibir o sarcômero cardíaco, e, composição farmacêutica
|
|
RS65302B1
(sr)
|
2019-07-17 |
2024-04-30 |
Cytokinetics Inc |
Oralne formulacije inhibitora srčanog sarkomera
|
|
MX2023002024A
(es)
|
2020-08-28 |
2023-05-10 |
Myokardia Inc |
Métodos de tratamiento con modulador de miosina.
|
|
CN117083275A
(zh)
|
2021-03-04 |
2023-11-17 |
赛特凯恩蒂克公司 |
心脏肌节抑制剂
|
|
PT4370116T
(pt)
|
2021-07-16 |
2025-03-14 |
Cytokinetics Inc |
Regimes de administração de aficamten para o tratamento da cardiomiopatia hipertrófica obstrutiva
|
|
EP4514355A1
(en)
|
2022-04-26 |
2025-03-05 |
MyoKardia, Inc. |
Methods of administering myosin inhibitors
|